Table 2.
Number of experiments | Immunogen | Carbohydrates/protein, mol/mol | IgG anti-LPS |
---|---|---|---|
3 | Octamer–HSA | 11 | 3.77 |
2 | Octamer–HSA | 20 | 11.1 |
4 | Dodecamer–HSA | 8 | 8.14 |
2 | Dodecamer–HSA | 10 | 9.52 |
2 | Dodecamer–HSA | 23 | 2.18 |
2 | Hexadecamer–HSA | 4 | 2.60 |
4 | Hexadecamer–HSA | 9 | 15.5 |
2 | Hexadecamer–HSA | 19 | 4.13 |
2 | O-SP-HSA | N.A. | 0.91 |
In 4 separate experiments, groups of 20 female 6-week-old general purpose mice from the NIH colony were injected s.c. with 2.5 μg of saccharide three times 2 weeks apart, and 10 from each group were exsanguinated 7 days after the second or third injections. Only the geometric mean IgG anti-LPS levels after the third injection of the conjugates are shown. Mice injected with saline or O-SP alone had no detectable antibody (data not shown). 11.1 vs. 3.77; P = 0.0003, 9.52, 8.14 vs. 2.18; P < 0.001; 15.5 vs. 2.60, 4.13; P = 0.0001; 15.5 vs. 8.14; P = 0.02, 15.5 vs. 9.52; NS. N.A., not applicable.
Excluding the tetramer.